Yu Gui Gu
26Patents
5h-index
81Co-inventors
68Inventor score
Filing activity: Apr 2, 1996 → Mar 17, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6455571B1 | Inhibitors of neuraminidases | Chemistry; Metallurgy | 48 | Expired |
| US8809314B1 | Cephalosporin compound | Chemistry; Metallurgy | 10 | Active |
| US8748627B2 | Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome | Chemistry; Metallurgy | 6 | Active |
| US6030969A | 5,6,7-trisubstituted-4-aminopyrido[2,3-D] pyrimidine compounds | Chemistry; Metallurgy | 5 | Expired |
| US9193729B2 | Inhibiting transient receptor potential ion channel TRPA1 | Human Necessities | 5 | Active |
| US8207350B2 | Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome | Chemistry; Metallurgy | 2 | Active |
| US7928243B2 | Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome | Chemistry; Metallurgy | 2 | Active |
| US6593314B1 | Neuraminidase inhibitors | Chemistry; Metallurgy | 2 | Expired |
| US8916709B2 | 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US5668141A | Trans-2,6-,3,6-and 4,6-diaza-5,6,6a,7,8,12b-hexahydrobenzo[c]phenanthrene compounds as dopamine agonists | Chemistry; Metallurgy | 1 | Expired |
| US6518305B1 | Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases | Chemistry; Metallurgy | 1 | Expired |
| US6831096B2 | Inhibitors of neuraminidases | Chemistry; Metallurgy | 1 | Expired |
| US8735595B2 | Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome | Chemistry; Metallurgy | 0 | Active |
| US9108966B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US8969570B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US8962844B2 | 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US6992069B2 | Tricyclic macrolide antibacterial compounds | Chemistry; Metallurgy | 0 | Expired |
| US8163769B2 | Antibacterial compounds | Chemistry; Metallurgy | 0 | Active |
| US8933232B2 | 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US6818654B2 | Antibacterial compounds | Chemistry; Metallurgy | 0 | Expired |
| US8933233B2 | 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US8940897B2 | 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US7196200B2 | Antibacterial compounds | Chemistry; Metallurgy | 0 | Expired |
| US8962843B2 | 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US8927724B2 | Isoxazole beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.